These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21092522)

  • 41. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases].
    Gao XY; Huang H; Li LD
    Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):648-52. PubMed ID: 20021783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.
    Okulu E; Erdeve O; Kilic I; Olukman O; Calkavur S; Buyukkale G; Cetinkaya M; Ulubas D; Demirel N; Hanta D; Ertugrul S; Gultekin ND; Tuncer O; Demir N; Bilgin L; Narli N; Yildiz D; Terek D; Koroglu OA; Seren C; Ozyazici E; Ozdemir R; Turgut H; Narter F; Akin Y; Ozyazici A; Zenciroglu A; Asker HS; Gokmen Z; Salihli M; Bulbul A; Zubarioglu U; Atasay B; Koc E;
    Front Pediatr; 2022; 10():864609. PubMed ID: 35573949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
    Yaseen H; Khalaf M; Rashid N; Darwich M
    J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.
    Li BJ; Jiang YJ; Yuan F; Ye HX
    Transfus Med; 2010 Feb; 20(1):66-9. PubMed ID: 19725902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ABO hemolytic disease: a comparative study of clinical severity and delayed anemia.
    Kanto WP; Marino B; Godwin AS; Bunyapen C
    Pediatrics; 1978 Sep; 62(3):365-9. PubMed ID: 568235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis.
    Chawla D; Parmar V
    Indian Pediatr; 2010 May; 47(5):401-7. PubMed ID: 19736369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials.
    Cao H; Wu R; Han M; Caldwell PHY; Liu JP
    PLoS One; 2017; 12(7):e0180746. PubMed ID: 28719639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
    Bakkeheim E; Bergerud U; Schmidt-Melbye AC; Akkök CA; Liestøl K; Fugelseth D; Lindemann R
    Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility.
    Sato K; Hara T; Kondo T; Iwao H; Honda S; Ueda K
    Acta Paediatr Scand; 1991 Feb; 80(2):163-6. PubMed ID: 1709770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.
    Ergaz Z; Arad I
    J Perinat Med; 1993; 21(3):183-7. PubMed ID: 8229608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of intensive blue double-lamp phototherapy in the treatment of ABO incompatibility and idiopathic severe hemolytic jaundice].
    Amato M; Von Muralt G
    Pediatr Med Chir; 1984; 6(1):95-8. PubMed ID: 6531243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
    Xu C; Bao Y; He Y; Wu M; Zhu J
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants].
    Clinical Research Collaborative Group of Yinzhihuang Oral Solution
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):663-8. PubMed ID: 22176900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.